Cipla partners with TEACH to create career opportunities for hearing-impaired youth

Cipla partners with TEACH to create career opportunities for hearing-impaired youth


  • Post By :

  • Source: Microbioz India

  • Date: 01 Dec,2023

Cipla Limited announced its partnership with Training and Educational Centre for Hearing Impaired (TEACH) for a program aimed to inspire and motivate hearing-impaired students, preparing them for the corporate world.

Last year the company conducted a pilot internship program for TEACH students and following the success this year the company expanded the program for more number of students offering a three-month internship at Cipla. These programs allowed the students to take up full-time positions after receiving positive feedback. With an aim to foster inclusivity and to provide students with valuable exposure, Cipla organised volunteering workshops where employees interacted with the students, offering insights of the healthcare and pharmaceutical sector and its operations.

The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals. Employees were trained in basic sign language comprehension, and interpreters were enlisted to ensure effective communication. The company introduced regular check-in sessions for both the teams and the interns to address any challenges that may arise in their day-to-day activities. Furthering support to the program, Cipla is dedicated to identifying and matching roles that best suit the skill sets of the hearing-impaired community. Moreover, it has also provided sponsorship for infrastructure enhancements at TEACH.

Commenting on the partnership, Dr. Raju Mistry, President and Global Chief People Officer, Cipla said, “At Cipla, we aim to foster a future-ready workforce where equity, diversity and inclusion are center stage. This partnership with TEACH is an extension of our commitment to create a workplace where everyone feels included, celebrated and are able to thrive. With this program, our goal is to equip promising young students with the necessary skills and knowledge to not just excel academically but also to make them highly employable in the ever-evolving job market.”


Established in 1935, Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets. Our strengths in the respiratory, anti-retroviral, urology, cardiology, anti-infective and CNS segments are well-known. Our 47 manufacturing sites around the world produce 50+ dosage forms and 1,500+ products using cutting-edge technology platforms to cater to our 80+ markets. Cipla is ranked 3rd largest in pharma in India (IQVIA MAT Sep’23), 2nd largest in the pharma prescription market in South Africa (IQVIA MAT Aug’23), and 4th largest by prescription in the US Gx inhalation products (IQVIA MAT Aug’23). For over eight decades, making a difference to patients has inspired every aspect of Cipla’s work. Our paradigm-changing offer of a triple anti-retroviral therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 is widely acknowledged as having contributed to bringing inclusiveness, accessibility and affordability to the centre of the HIV movement.

About Author